ArticleJournal of translational medicine2026
A pan-viral map of host dependency factors from multi-omics integration and machine learning across influenza A, SARS-CoV-2, Zika, and dengue viruses.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHost dependency factors (HDF) are essential for viral replication and are promising targets for broad-spectrum antivirals. However, most work has focused on individual viruses or individual data types, limiting our understanding of shared host mechanisms across viruses.
methodsWe developed a pan-viral framework that integrates multi-omics data-including genome-wide perturbation screens, single-cell transcriptomes and viral interactomes-and combines graph-based learning with classical machine-learning models to prioritize HDF for four RNA viruses (SARS-CoV-2, influenza A virus, dengue virus and Zika virus).
resultsAcross viruses, the framework achieved high discrimination, with area under the receiver operating characteristic curve (ROC-AUC) greater than 0.90 on benchmark datasets, and identified a conserved signature of 118 genes shared by all four viruses and 427 genes shared by at least three. These genes converge on recurrent host programmes such as clathrin-mediated entry and endomembrane trafficking, nuclear transport, RNA processing and stress granules, and proteostasis and ubiquitin-proteasome signalling. The pan-viral signature generalizes beyond the training set, as genes shared by three or more viruses are strongly enriched among top-ranked Ebola virus candidates. We further provide a prioritized shortlist and an experimental validation roadmap to guide follow-up perturbation studies.
conclusionsOur integrative multi-omics and machine-learning approach outlines a prediction-based, data-driven map of pan-viral host liabilities and highlights tractable opportunities for host-directed therapy against diverse RNA viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.